Floatz logo

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM

DLBCL

Ruijin Hospitalprotein_peptidePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the DLBCL cohort.

Asset / SponsorPhaseRating
Selinexor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BBB
rc48-adc
Seoul National University Hospital
Phase 2BB
Pyrotinib
Seoul National University Hospital
Phase 2BB
Vistusertib
Acerta Pharma BV
Phase 2B
Ublituximab
TG Therapeutics, Inc.
Phase 2/3CCC

View all 37 →

Same molecule, other indications

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
69 / 100
View asset →
neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
Hodgkin DiseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →